Spots Global Cancer Trial Database for invasive aspergillosis
Every month we try and update this database with for invasive aspergillosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation Therapy | NCT06382922 | Invasive Asperg... | 60 Years - 80 Years | University of Rome Tor Vergata | ||
Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients | NCT00982540 | Invasive Fungal... Invasive Asperg... Invasive Fusari... | caspofungin as ... | 18 Years - | Universidade Federal do Rio de Janeiro | |
Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients | NCT03067350 | Invasive Asperg... Haematological ... Voriconazole | 18 Years - | University Hospital, Grenoble | ||
Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients | NCT00982540 | Invasive Fungal... Invasive Asperg... Invasive Fusari... | caspofungin as ... | 18 Years - | Universidade Federal do Rio de Janeiro | |
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia | NCT01615809 | Invasive Pulmon... Lymphoblastic L... Myeloblastic Le... Lymphoblastic L... Myeloblastic Le... | AMPHOTERICIN B | 3 Years - 17 Years | Fundació Sant Joan de Déu | |
Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy | NCT03221075 | Invasive Asperg... | Registry | - | University Hospital of Cologne | |
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy | NCT04743544 | Adverse Drug Re... | Voriconazole | 2 Years - 18 Years | Dokuz Eylul University | |
Invasives Aspergillosis in Acute Myeloid Leukemia | NCT02900430 | Acute Myeloid L... Invasive Asperg... | Patients withou... Patients with a... | 18 Years - | University Hospital, Brest | |
Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation Therapy | NCT06382922 | Invasive Asperg... | 60 Years - 80 Years | University of Rome Tor Vergata | ||
Surveillance for Nosocomial Infections in Pediatric Cancer Patients | NCT00843804 | Nosocomial Infe... Bloodstream Inf... Invasive Asperg... | - 21 Years | University Hospital, Bonn | ||
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy | NCT04743544 | Adverse Drug Re... | Voriconazole | 2 Years - 18 Years | Dokuz Eylul University | |
Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients | NCT03067350 | Invasive Asperg... Haematological ... Voriconazole | 18 Years - | University Hospital, Grenoble | ||
Invasives Aspergillosis in Acute Myeloid Leukemia | NCT02900430 | Acute Myeloid L... Invasive Asperg... | Patients withou... Patients with a... | 18 Years - | University Hospital, Brest | |
Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation Therapy | NCT06382922 | Invasive Asperg... | 60 Years - 80 Years | University of Rome Tor Vergata | ||
Invasives Aspergillosis in Acute Myeloid Leukemia | NCT02900430 | Acute Myeloid L... Invasive Asperg... | Patients withou... Patients with a... | 18 Years - | University Hospital, Brest | |
Diagnostic and Management Strategies for Invasive Aspergillosis | NCT00816088 | Invasive Asperg... Neutropenia | 18 Years - | King's College Hospital NHS Trust |